Literature DB >> 2174484

Resiniferatoxin and its analogs provide novel insights into the pharmacology of the vanilloid (capsaicin) receptor.

A Szallasi1, P M Blumberg.   

Abstract

Capsaicin, the pungent constituent of chili peppers, represents the paradigm for the capsaicinoids or vanilloids, a family of compounds shown to stimulate and then desensitize specific subpopulations of sensory receptors, including C-polymodal nociceptors, A-delta mechanoheat nociceptors and warm receptors of the skin, as well as enteroceptors of thin afferent fibers. An exciting recent advance in the field has been the finding that resiniferatoxin (RTX), a naturally occurring diterpene containing a homovanillic acid ester, a key structural motif of capsaicin, functions as an ultrapotent capsaicin analog. For most of the responses characteristic of capsaicin, RTX is 100-10,000 fold more potent. Structure/activity analysis indicates, however, that RTX and related homovanillyl-diterpene esters display distinct spectra of activity. Specific [3H]RTX binding provides the first direct proof for the existence of vanilloid receptors. We expect that the RTX class of vanilloids will promote rapid progress in understanding of vanilloid structure/activity requirements and mechanism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2174484     DOI: 10.1016/0024-3205(90)90518-v

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  33 in total

1.  Retinal cell death induced by TRPV1 activation involves NMDA signaling and upregulation of nitric oxide synthases.

Authors:  Mauro Leonelli; Daniel O Martins; Luiz R G Britto
Journal:  Cell Mol Neurobiol       Date:  2013-01-17       Impact factor: 5.046

2.  Constrained TRPV1 agonists synthesized via silver-mediated intramolecular azo-methine ylide cycloaddition of α-iminoamides.

Authors:  Thomas O Painter; Krisztian Kaszas; Jacklyn Gross; Justin T Douglas; Victor W Day; Michael J Iadarola; Conrad Santini
Journal:  Bioorg Med Chem Lett       Date:  2013-12-21       Impact factor: 2.823

3.  The emetic and anti-emetic effects of the capsaicin analogue resiniferatoxin in Suncus murinus, the house musk shrew.

Authors:  P L Andrews; F Okada; A J Woods; H Hagiwara; S Kakaimoto; M Toyoda; N Matsuki
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

4.  A non-pungent triprenyl phenol of fungal origin, scutigeral, stimulates rat dorsal root ganglion neurons via interaction at vanilloid receptors.

Authors:  A Szallasi; T Bíró; T Szabó; S Modarres; M Petersen; A Klusch; P M Blumberg; J E Krause; O Sterner
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

Review 5.  Terpenes and lipids of the endocannabinoid and transient-receptor-potential-channel biosignaling systems.

Authors:  David R Janero; Alexandros Makriyannis
Journal:  ACS Chem Neurosci       Date:  2014-06-05       Impact factor: 4.418

6.  Reproducibility of the capsaicin-induced dermal blood flow response as assessed by laser Doppler perfusion imaging.

Authors:  B J Van der Schueren; J N de Hoon; F H Vanmolkot; A Van Hecken; M Depre; S A Kane; I De Lepeleire; S R Sinclair
Journal:  Br J Clin Pharmacol       Date:  2007-06-19       Impact factor: 4.335

7.  Vanilloid receptors in the urinary bladder: regional distribution, localization on sensory nerves, and species-related differences.

Authors:  A Szallasi; B Conte; C Goso; P M Blumberg; S Manzini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-06       Impact factor: 3.000

Review 8.  Resiniferatoxin in the treatment of interstitial cystitis: a systematic review.

Authors:  Eleni G Mourtzoukou; Christos Iavazzo; Matthew E Falagas
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-06-19

9.  [3H]resiniferatoxin binding by the vanilloid receptor: species-related differences, effects of temperature and sulfhydryl reagents.

Authors:  A Szallasi; P M Blumberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-01       Impact factor: 3.000

10.  Selective targeting of TRPV1 expressing sensory nerve terminals in the spinal cord for long lasting analgesia.

Authors:  Joseph A Jeffry; Shuang-Quan Yu; Parul Sikand; Arti Parihar; M Steven Evans; Louis S Premkumar
Journal:  PLoS One       Date:  2009-09-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.